Dianthus Therapeutics DNTH
NASDAQ DNTH
$89.30 +0.49 (+0.55%)
At close: Nov 11, 2026 · 4:00 PM EST

Dianthus Therapeutics (DNTH) Depreciation & Amortization (CF) (2017 - 2026)

Updated

Dianthus Therapeutics (DNTH) recorded Depreciation & Amortization (CF) of $27,000 in Q3 2025, up 8.0% from $25,000 a year earlier but down 10.0% from the prior quarter.

Analysis

Dianthus Therapeutics (DNTH) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

On a TTM basis, Dianthus Therapeutics' Depreciation & Amortization (CF) came in at $110,000 as of Sep 30, 2025, up 22.2% year-over-year; for FY2024, it came in at $96,000, up 43.3% from FY2023.

  • Annual Depreciation & Amortization (CF) has a five-year compound annual growth rate of -44.6% (FY2019 to FY2024).
  • Across earlier years, Depreciation & Amortization (CF) came in at $67,000 in FY2023 (-96.5%), $1.93 million in FY2022 (-4.7%), $2.02 million in FY2021 (+1.0%) and $2 million in FY2020 (+8.5%).
  • Quarterly Depreciation & Amortization (CF) has ranged from $19,000 in Q3 2023 to $535,000 in Q4 2021 over the past five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased for five consecutive quarters, with an average decline of 9.7% over the last seven quarters.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 31.6% in Q3 2024, against a decline of 96.0% in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $30,000 (Q2 2025), $27,000 (Q1 2025) and $26,000 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Dianthus Therapeutics 5.00 Bn 4.95 Bn - 37,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 37,000.00
Jun 30, 2026 37,000.00
Mar 31, 2026 32,000.00
Dec 31, 2025 27,000.00
Sep 30, 2025 27,000.00
Jun 30, 2025 30,000.00
Mar 31, 2025 27,000.00
Dec 31, 2024 26,000.00
Sep 30, 2024 25,000.00
Jun 30, 2024 23,000.00
Mar 31, 2024 22,000.00
Dec 31, 2023 20,000.00
Sep 30, 2023 19,000.00
Mar 31, 2023 421,000.00
Dec 31, 2022 466,000.00
Sep 30, 2022 471,000.00
Jun 30, 2022 477,000.00
Mar 31, 2022 511,000.00
Dec 31, 2021 535,000.00
Sep 30, 2021 532,000.00
API Access

Dianthus Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=DNTH&period=max&api_key=YOUR_API_KEY